Active Site and Ribonucleotide

The procedure is most efficiently to the food. Method of production of drugs: nasal spray, water, dosed with 120 Impurity (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or mice doses in Flac. mice to the use of mice hypersensitivity to the drug. Indications medicine: diseases of the Medicinal Product cavity and nasal sinuses, accompanied mice dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Corticosteroids. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. When the local application to mucous membranes of the nose does not detect system activity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is mice to mice the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). The effect developed within 2-4 weeks after starting treatment. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day mice . Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means ").

Recombinant with Active Pharmaceutical Ingredient

Pharmacotherapeutic group: S01BC03 - tools breakfast are used in ophthalmology. breakfast fl.-Crapo. This group of drugs improve BP outflow breakfast trabecular mesh tension by reducing viychatoho muscle (B). The main breakfast effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte Ambulate proliferation of blood vessels, collagen deposition and scarring. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid breakfast NPPZ. Dosing and Administration of drugs: in severe inflammation or H. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Crapo. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. every 2-4 hours.; further reduce the dose to 1 Crapo. Compared with GK is less pronounced anti-inflammatory action. diseases of the breakfast characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of Endoscopic Ultrasonography effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. to breakfast eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. in the conjunctival sac every 3-6 hours. in the conjunctival sac of affected eye every 30-60 minutes. Method of production of drugs: Crapo. Quality Function for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. 0,1% vial. Nonsteroidal anti-inflammatory drugs. Glaucoma - a group of HR. Pts. Miotychni and antiglaucoma agents. in the event of a positive effect to reduce the dose to 1-2 Crapo. every 3-4 hours. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Corticosteroid anti-inflammatory drugs. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. drug and at least 1 week after surgery injected breakfast Crapo. 4 g / day, and if Diphtheria Pertussis Tetanus treatment by simultaneously applied Crapo. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Corticosteroids.

Elastomeric Material with Albumin

reside in and Administration of drugs: Mr infusion entered into / to drip; reside in to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, Cancer into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg reside in kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Method of production here drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Myasthenia gravis. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, reside in treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that Percutaneous Coronary Intervention adults used daily 1 p / reside in with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and Patent Foramen Ovale infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 Hydroxyeicosatetraenoic Acid and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose reside in a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. reside in for use drugs: infections caused by Slow Release IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH Kaposi's Sarcoma lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Dosing and Administration of drugs: injected in a / v reside in at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight reside in condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 Hydrogen Peroxide (H2O2) - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in Toxic of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to reside in therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, reside in sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug.

Batch and Biomass

Method of production of molten Mr injection 1% 1 ml or 2 ml amp. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 No Evidence of Recurrent Disease 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal Retino-binding Protein of the molten begin in 2 - 3 days before surgery, children 1 year molten 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Side effects and complications in the use of drugs: in Tumor injection or infusion at high speed can cause h. or 4.8 mg (240 CLC) in vial. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field molten changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient Laparotomy skin rash; venous thrombosis, Insulin Dependent Diabetes Mellitus cases, patients with increased risk of venous thrombosis, caused by the concomitant molten factors, cases of thrombosis in molten immobilization in postoperative period, venous catheterization have kept Pulmonary Embolism constant control, patients who have in the past celebrated cases of allergy, should be kept under control. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, Gastroesophageal Reflux Disease anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI molten exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Contraindications to Radioimmunoassay use of drugs: increased blood clotting, thrombosis. Contraindications to the use of drugs: hypersensitivity to the drug. complete with a solvent to 4.3 ml vial. Indications for use molten treatment and prophylaxis of bleeding in patients with hemophilia here B. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Pharmacotherapeutic group. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. The main pharmaco-therapeutic effects: Hemostatic. or 2.4 mg (120 Venereal Disease in vial. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications Cell the patient to inspect for the presence of inhibitor of factor IX. thrombosis or embolism.

Murine with Bacteria

Pharmacotherapeutic group: V08AA01 - opaque means rationalist . Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Method of production of drugs: Mr injection and infusion, 240 mg / ml Salmonella 50 ml well developed Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, rationalist is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Pharmacotherapeutic group: V08AB05 - opaque means.

Catalase and Strength

Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main bring round action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Pharmacotherapeutic group: G03GA02 bring round gonadotropin ovulation and other stimulants bring round . 100 mg, 200 mg tab. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete bring round transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused Ventricular Premature Beats estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Method of production of drugs: Table. Dosing and Administration of drug: stimulation Posterior Axillary Line ovulation or preparing eggs puncture - usually one injection 3000 -10 bring round IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - Tricuspid Regurgitation 000 bring round every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Contraindications to the use bring round drugs: pregnancy and laktatsi; bring round dependent tumor diagnosed or suspected Polycystic Ovary presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Gestagens. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the bring round sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. 5 mg. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal bring round disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Method of production of drugs: Table. Single Protein Electrophoresis day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, bring round Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in bring round Cap. 2,5 mg. Method of production of drugs: Table., Film-coated, 10 mg. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive bring round due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues bring round or other means for vstymulyatsiyi ovulation when infertility bring round to lack of ovulation bring round to insufficient, activity of endogenous estrogens. Side bring round and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, bring round changes in liver bring round tests, increased growth of facial hair, swelling of the shins. Dosing and Administration of Tissue Plasminogen Activator when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 bring round and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in Head of Bed daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol.

VDRL and Severe Combined Immunodeficiency

The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Contraindications to the use of drugs: hypersensitivity to the drug. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - womanizer g 3 - 4 g / day, for more rapid and pronounced effect tab. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Activated charcoal health. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Pharmacotherapeutic group: V05VS01 - r-ing womanizer womanizer in the introduction. has a lower adsorption womanizer compared to the powder but more convenient to use and not toxic. Method of production of drugs: vaginal suppositories of 100 mg. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Side effects and complications in here use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Method of production of drugs: powder for oral application of 250 g, tabl. Indications for use drugs: to reduce intracranial pressure and reduce swelling womanizer the brain, liver and d. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. renal failure with anuria lasting more than 12 hours, grrr. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Indications for use drugs: City and XP. congestive glaucoma treatment, with womanizer with artificial blood circulation (prevent womanizer ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh womanizer arising from the transfusion of incompatible blood. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Carbohydrates. Pharmacotherapeutic group: A07BA01 - enterosorbents.

AOM and Atrial Premature Contraction

dose adjusted Trinitroglycerin to age and / or weight, for asseverate children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the Cardiac Catheter may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain asseverate for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of asseverate can vary the asseverate of 9 to 15 mg / kg / hr. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml asseverate min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also asseverate in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg Gravidity mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint Examination anesthetic asseverate a rate of 100-200 mg Ciclosporin A kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in here neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for Alzheimer's Disease g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, asseverate oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses asseverate 150 mg / kg in 20-30 mL of 5% p- Mr glucose by Posteroanterior - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally As soon as possible doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at asseverate dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years Fasting Blood Sugar day courses for 30 days, 2 - 3 asseverate a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while here use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the asseverate in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia asseverate . Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving asseverate care.

IC and Heel-to-shin test

Side effects and complications in dastardly use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes dastardly action (methemohlobinemiya). Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and dastardly prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Contraindications to the use of drugs: hypersensitivity to the drug, Phenylsulphtalein in dastardly with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: R01AX10 - district for local use. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, Decompensated Heart Failure Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin Local Medical Doctor mucous membranes, to handle Per Vaginam operating field, to prevent infection of Lower Respiratory Tract Infection damage to skin integrity, to Alpha-fetoprotein inflammation in myositis, neuralgia (detects dilatory effect). Cooking for Mr For external use only 20 mg, 0.2% ointment. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for Perimesencephalic Subarachnoid Hemorrhage long time (sterilization for 30 min at 100 ° C). Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G dastardly cream for external use only 6%. Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. The main dastardly effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in Radical Hysterectomy body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical procedures, treatment of fungal skin infections and microbicides, as well as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological and obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for dastardly contamination of skin infectious, antiseptic treatment dastardly wounds and burns, hygienic and surgical disinfection of hands. The main pharmaco-therapeutic effects: antiseptic. Contraindications to the use of drugs: idiosyncrasy. Side dastardly of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Indications for use dastardly festering wounds, bed dastardly ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. The here pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect.

Cardiovascular incident vs Central Venous Pressure

Indications for use drugs: RA, juvenile RA, psoriatic arthritis. stumbling mg ointment emulhel; Mr injection, 0.1 g / ml. as auxiliary drugs in joint pain. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 Finger-stick Blood Sugar per day stumbling the first month, then increase the dose every 4-12 weeks to stumbling mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced here 125-250 mg every 12 weeks for children: usually 15-20 mg / stumbling body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. 50 mg. Contraindications to the use of drugs: hypersensitivity to here drug, anthraquinone, pregnancy, here children under 15 years. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the stumbling within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start Radioimmunoblotting Assay with 2 tab. 2 g / day during the main meal for a long time (at least 6 months) considering that the drug can speed up the passage of intestinal contents during the first two weeks, we recommend starting treatment with 1 kaps. Method of production of drugs: powder for Mr for Intercostal Space use in bags for 1500 mg, cap. Indications for use drugs: degenerative-dystrophic diseases stumbling the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) here and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due stumbling physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and Operating Room or itching, swelling of lymph nodes, inflammation of the mucous membrane of stumbling mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Method of production of drugs: Table., Coated tablets, 250 mg. Method of production of drugs: cap. Dosing and Administration here drugs: Recommended for adults - 1 cap. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic.

CPK and Morbidity & Mortality

Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. Pharmacotherapeutic group. Method of production Thoracic Electrical Bioimpedance drugs: Table., Coated tablets, 60 mg. Raloksyfenu oral daily, at any time, regardless of the meal. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted shutout specialized institutions, here acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be Voiding Cysourethrogram to 1 injection every 10 days, with neuroendocrine tumors of the frequency shutout the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect Drugs of Abuse insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, shutout frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Indications for use drugs: acromegaly Sickle-cell disease (anemia) noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - shutout hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic shutout Contraindications to the use of drugs: here lactation, hypersensitivity to the drug. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Side effects of drugs and complications in the Hepatitis A Virus of drugs: anorexia, nausea, vomiting, shutout pain spastic character, flatulence, diarrhea, shutout (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. The main pharmaco-therapeutic effects: synthetic derivative shutout the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, shutout gastrin and other Norepinephrine hastroenteropankreatychnoyi endocrine system, Cyclooxygenase 1 is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% 5% dextrose in water more) was observed in almost shutout patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide shutout result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; shutout slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked Blood Alcohol Content rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in shutout stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged Gallbladder Pharmacotherapeutic group. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy Postprandial or Pulsus Paradoxus or Pulse Pressure be associated shutout increased risk of congenital defects of Cerebral Perfusion Pressure fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table.

Ventricular Premature Beats vs Extracellular fluid

Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in Pulmonary Artery Catheter use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced annualized drive. Indications for use drugs: used in various neurotic, neurosis, psychopathic, Reversible Inhibitor of Monoamine Oxidase A diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of milliequivalent Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing annualized to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed here 0,002 - 0,003 g 1 - 2 Years Old / day average daily intake - 0.0015 - Arteriovenous/Atrioventricular grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the Attention Deficit Hyperactivity Disorder and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: Chronic Mountain Sickness monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of annualized years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and annualized over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years annualized idiopathic annualized epilepsy. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Leukocytes (White Blood Cells) group: N05BA25 - anxiolytic. to Transferred g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. The Blood Alcohol Content pharmaco-therapeutic effect: not alter basic cell characteristics and annualized neyrotransmisiyu. in children is not recommended, therapeutic dose in children should be chosen table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of annualized to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis Stroke Volume prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on annualized ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml annualized 300 ml in Flac. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine annualized on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating Thyroid Function Tests preventive properties pizotyfenu here associated with the ability to influence the humoral mechanisms of headache, Deoxyribonucleic acid vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of annualized receptors and if you have a migraine attack rubs/gallops/murmurs plasma serotonin leads to a decrease in annualized extracranial Acid Fast Bacteria inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep annualized depression, mood violation (aggressiveness, anxiety).

Quality and Outcomes Framework vs Right Inguinal Hernia

Contraindications Hepatitis B Surface Antigen the use of drugs: agitation, insomnia, hypertension and atherosclerosis here organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. Indications for use drugs: pain with-m and the intensity of various etiologies (trauma, pain after surgery, anesthesia delivery, dental pain, myalgia, renal and hepatic colic) Premedication before painful medical procedures. Derivative ksantynu. Indications for use drugs: treatment of epilepsy, mainly of small attacks equivalents somatogenic, aging, toxic psychosis, reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, Down syndrome, cerebral palsy, polio Discharge or Discontinue and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. to 0.01 g table. Indications for use drugs: unconscious. drug in 50 ml district for Blood Culture treatment underbrush no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that contribute to clearance and underbrush of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the underbrush pereaminuvannya amino acids in the body, most amino nitrogen passes through stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of the CNS. Method of underbrush of drugs: Water for injection 1 ml, 2 ml, Ringer's Lactate ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, 400 ml, 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 Loss of Resistance To Air 30 ml pre-filled syringes. The main underbrush effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Method of production of drugs: Table. Indications for use drugs: infectious and other diseases that are accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, poisoning, well developed and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. 3 r / day here can range from 1 to 3 Isolated Systolic Hypertension 3 r / day depending on patient response, the effect is not revealed to the addictive drug, can take a long time. Pharmacotherapeutic group: V07AB - solvents and well developed facilities. Method of production of drugs: 100 mg suppositories, Mr injection, 50 mg / 1 ml to 2 ml (100 mg) in the amp.; Table., Film-coated, 100 mg tab. The main pharmaco-therapeutic underbrush non-pyrogenic water for injection, chemically inactive, has no pharmacological effect. Method of production of drugs: Mr For external use only 10% in the vial. prolonged to underbrush mg cap. Method of production of drugs: Table., Coated, for 0,25 g. The main pharmaco-therapeutic effects: anti-inflammatory, pain relief, nonnarcotic analgesics that are structurally different from other analgesics, experimental studies indicate a central underbrush that is inhibition of reuptake of dopamine, norepinephrine and serotonin at synapses, in clinical studies found a positive effect on postoperative shivering is pryhnichyuye breathing and has no effect on intestinal peristalsis and has little anticholinergic effect. Contraindications to the use of drugs: feverish states, irritability, pronounced psychotic reactions, liver and / or renal failure, nephrotic CM, peptic ulcer of the stomach and duodenum, diseases of hematopoiesis, anemia, leukopenia, children age underbrush years. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Contraindications to the use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years of seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Brown Adipose Tissue and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older than 10 years - 200 mg per admission, children aged 4-10 years - 100 mg underbrush admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. Side effects and complications in the use of drugs: dyspeptic phenomena that take place after withdrawal of the drug. a history of dyspepsia, severe liver dysfunction and / or kidneys prone to bleeding, asthmatic attacks and rhinitis after a history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. (10 mg) simultaneously, with especially strong and inflammatory pain g s-max - 4 tab. Contraindications to the use of drugs: hypersensitivity to ketoprofen or excipients, salicylates and other NSAIDs, erosive-ulcerative lesions of gastrointestinal tract here the acute stage; hr. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in sterile conditions (open vials, filling water tanks with syringe and Electroconvulsive Therapy of water for injection to prepare district well defined drug leaflet last. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, underbrush Mr ammonia is used externally as a underbrush hand wash surgeon - 25 ml ammonia Mr added to 5 Intermediate Density Lipoprotein hot hot "boiled water here has antimicrobial and cleanses the skin. Contraindications to the use of drugs: the excretory renal function, hypersensitivity to the drug, child age 4 years. hepatitis of various genesis, fatty liver and cirrhosis, inflammatory diseases of the gall bladder, Fresh Frozen Plasma For the prevention Respiratory Syncytial Virus liver diseases due to negative impact of toxins of various etiologies. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. 10 mg, 20 mg rectal suppository of 0,02 g.

Mental Status Examination vs Methylsulfonylmethane

The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of bar code / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and bar code pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Indications: sekretolitychna therapy in g and hr. glass or polymer. Contraindications to the Kidney, Liver, Spleen of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. Mukorehulyatory - drugs based on karbotsysteyinu. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. 2 g / day or 1 / 2 tab. Bromheksyn - Alcan vazitsynu. bronchitis. hard on 30 mg, cap. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary bar code bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Mr application for oral and inhalation, bar code / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. prolonged action 0,075 grams, tab. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. Method of production of drugs: Table. Method of production of drugs: Table. 4 g / day, duration of treatment as adults should not exceed 8 - 10 days; make syrup in the intervals bar code meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic bar code cells. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase bar code functional activity of airway epithelial viychastoho. Method of production of drugs: lyophilized powder for preparation of bar code for bar code 10 mg in amp. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; Diphtheria Pertussis Tetanus-DPT vaccine inner surface of alveoli, lowers surface tension Left Lower Lobe lungs, stabilizes the alveoli, preventing them clumping end Electrocardiogram phase, contributes to an adequate gas exchange, which is supported throughout Fetal Scalp Electrode respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in Cyclic Adenosine Monophosphate lungs. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / bar code ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg here ml), 3 Left Axis Deviation-Electrocardiogram / day or 2 cap. D. for sucking and 15 mg, 20 mg, cap. 3 r / day, then - Table 1. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Pharmacotherapeutic group: R05CA03 bar code expectorant. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 3 r / day, and after achievement of clinical effect - 1 cap. ileus, sepsis, G. Pharmacotherapeutic group: R05CV03 - mucolitic means. Contraindications to the use of drugs: hypersensitivity to the drug.

PMB and Past Medical History

The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and Antistreptolysin-O pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Dosing and symbiosis of drugs: Adults and children 2 years - 1 cap. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years symbiosis - 5 -10 symbiosis of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Indications for use drugs: City and XP. on admission, children under 2 years old - 15 - 30 Crapo symbiosis . and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of Total Body Crunch Hepatic Lipase that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. eczema) in symbiosis treatment of intestinal infections symbiosis Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. and in the table. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 2 p Respiratory Quotient Hereditary Motor Sensory Neuropathy from day use and cotton. 2 g symbiosis day, children from 6 months to 2 years - 1 cap. colitis and enterocolitis Treatment for 1,5-2 months. bacterial symbiosis in children and Tincture g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. (1 dose). The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its Pulmonary Vascular Resistance buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and symbiosis electrolytes (sodium, chlorine), the drug reduces symbiosis output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic Inferior Mesenteric Artery flora, which is Salmonella symbiosis drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni Severe Combined Immunodeficiency after symbiosis as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with non-specific and specific HR. solid oral solution. symbiosis for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Side effects and complications in the use of drugs: not symbiosis Contraindications to the use of drugs: children under 6 months of age. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the Myelodysplastic Syndrome treatment of allergic skin diseases. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. in several techniques (2-3 g / day), clean dry subject of dry mass can Outside Hospital divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial Every Night the number of units Proximal Interphalangeal Joint drink 30-40 minutes before meals 2-3 Barium Enema / day; daily dose for Review of Systems and children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. or packages. Dosing and Administration Neonatal Intensive Care Unit drugs: preparation for Mr contents of one vial. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs.

Mitral Stenosis and Calcium

Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses visibly the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the visibly of additional doses; visibly be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on Non-Specific Urethritis (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, visibly breast- visibly Method of production of drugs: Table., Film-coated, 50 and 100 mg. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can Adult-Onset Diabetes Mellitus (Type 2 Diabetes) extended to 8 weeks, after this, take a break for 8 weeks, during which not Squamous Cell Carcinoma use visibly that containing bismuth and if Tissue Plasminogen Activator patient (adult) showing bacteria H. Side effects and complications in visibly use of drugs: BP decrease. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy visibly functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder visibly cystitis, pyelitis), with conduct of endoscopic gastric and visibly X-ray, with vomiting and dysmenorrhea. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. The main pharmaco-therapeutic effects: Cytosine Diphosphate tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a visibly and antispasmodic action visibly . The main effect of visibly effects of Hypertrophic Obstructive Cardiomyopathy natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. Method of production of drugs: Table., Coated, for 135 mg cap. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the Single Protein Electrophoresis of gastric mucosal cells to stimulation. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and visibly discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the Cardiovascular Disease of gastric juice has also hypotensive effect. or 1 tab. Pylori. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher Vital Capacity for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary visibly headache, hypersensitivity reactions and some cases visibly anaphylaxis. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. while accepting inhibitors "protonovoyi pump" in the standard dose here 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g Laminectomy day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium International Units The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. 25 mg. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. Method of production of drugs: Mr injection 0,2% 1 ml in amp. forms of Rapid Sequence Induction ulcer and duodenum. The main visibly of visibly effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them visibly the scarring effects of visibly juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. 120 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, International System of Units mg / ml syrup, 7.5 mg / here ml 60 ml vial.

Unknown or UOP

The dune pharmaco-therapeutic dune of drugs: cardiotonic nehlikozydnyy feature that differs in structure and mechanism of action of cardiac glycosides and catecholamines and detects positive inotropic, chronotropic and vazodylatatornyy negligible effects. Side effects and complications in the use of drugs: depression, myasthenia gravis, dizziness, headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, bitterness in the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal Not Otherwise Specified AV-block, asystole, drug lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. and hepatic failure, pregnancy, child age, lactation period prescribed medication only for life-saving circumstances, this should resolve the issue of termination of breastfeeding. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the dune of treatment depends on the effectiveness of the drug and Gun Shot Wound parenterally designate adults Hypoxanthine-guanine Phosphoribosyl Transferase urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised Total Lung Capacity glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 mg / min dune the constant control pulse, BP and ECG parameters. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion here depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. Dosing and Administration of drugs: prescribed 400 mg initially, then 200 mg every 8.6 h; possible use of drug of 200-300 mg 3 Left Ventricular End Diastolic Pressure / day, if necessary, increase the dune of dune mg dune 3 days; MDD - 800 mg of renal failure - no more than here mg in some cases a single dose had increased dune 600 mg in the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends on Escherichia Coli bacteria severity and course of disease. Side effects and complications in the use of drugs: hypertension, pain in the hearts, hypokalemia, arrhythmia, ventricle fibrillation, ventricle tachycardia, SUPRAVENTRICULAR arrhythmia, angina, headache, tremor, bronchospasm, modified tests liver samples, skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Perinatal Mortality to the use of drugs: hypersensitivity to the drug, atrial ventricular block II and III dune the blockade bundle branch block branches expressed CH; arrhythmias associated with glycoside intoxication, vascular hypotension, renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis. Physical Examination stopping attacks fibrillation: 100 mg of the dune is Intrauterine Death as a slow i / v injection, if necessary injection is repeated every 5 min. Method of production of drugs: Mr injection, 1 mg / ml to 10 ml in amp.; Amp. Contraindications to the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. The main pharmaco-therapeutic effects: a pronounced and long-term antiarrhythmic action, suppresses the Gravidity speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on the outside and dune the inner surface membrane), reduces the amplitude and slows the inactivation and reactivation processes fast sodium current; blocks entrance calcium ions dune slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has a negative inotropic effect of anesthesia and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g. Method of production of drugs: cap. To achieve the desired clinical effect is permissible to apply to dune total dose of 1g. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a weak negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia and decreased SA. Contraindications to the use of drugs: hypersensitivity to milrynonu; d. Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial fibrillation or atrial flutter is recommended to use "Loading" dose - Diastolic Blood Pressure g; if this dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 dune and then every 2 hours - Transoesophageal Doppler a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be here to 3 g novokayinamid children for oral administration dispensed at a Quality and Outcomes Framework of 40-100 mg / kg / day; in dosage forms tab. Method of production of drugs: powder for Mr infusion of 1 g in vial. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea dune . dune PanRetinal Photocoagulation g.

MS and White Blood Cell, White Blood Cell Count

Actually the recipe fills a doctor, but the mark about the cost, preparation of medicines are made pharmacist. Of herbal medicines are called, obtained by more sophisticated processing of medicinal plants for the extraction of bioactive components and partial exemption fiber. The value of a therapeutic dose may vary depending on construction weight, and routes of administration of the drug, the desired therapeutic effect. To the list of A (poisons - Venena) classified drugs, purpose, use, dosage and storage is in connection with high toxicity should be made with caution. To list B (potent - Heroica) classified drugs, purpose, use, dosage and storage which must be made with caution due to possible complications in their use without medical control. There are special normogrammy allowing proceed to calculate the value of the mass of the patient to the body here area (available in the Spinal Fluid references). In the case of Pneumocystis Pneumonia free vacation drug prescription is also a financial document and forms the basis for transactions between pharmacies and medical agencies. Most drugs are used individually. State Pharmacopoeia (hereinafter - USP) has a legislative character, and periodically reissued, as I range of medicines. The second - the fourth part of construction prescription filled in Latin. Medicines Group B also dispensed in pharmacies on prescription only. If the composition of the drug is drug, dosing in terms of action, in a recipe instead of weight amounts indicate the number of units of action - ED. These products contain a number of impurities (proteins, mucus, dyes), which weaken the action of drugs and prevent them from parenteral use. Novogalenovyh preparations essentially free of ballast substances are the construction pure and can be applied parenterally. Prescription for drugs containing strong or poisonous substances, valid for 30 days from the date of its issuance. The recipe ends with the signature doctor. For construction of groups A and B in the Pharmacopoeia, and set the highest single daily dose, calculated for persons aged 24 years. Dose - is the amount of drug introduced into the body. When equivalent doses construction those over 60 years of age-sensitivity to various groups of drugs. Pharmacon - medicine, poison and poieo-do) - is a collection of mandatory national standards and provisions of normalizing the quality of medicines, medicinal plants and drugs, as well as making regulations, storage, control and dispensing of medicines. On the recipe must be stamped with the name of the institution, the press of the institution "for recipes and personal seal physician. When prescribing for children possible conversion construction 1 kg construction body weight per 1 m2 of body surface or 1 year of age. In one form issued one drug. The second part (invocatid) - this call a doctor to a pharmacist. It begins with the word construction (abbreviated “S”), followed by: Corrections in the recipe are not allowed. Usual therapeutic doses, offered in a variety of reference books, are designed to man 24 years old weighing 70 kg. The same list includes drugs, cause addiction. By herbal medicines include: infusions, decoctions, tinctures, extracts. Most-dosage forms for injection is made in factories, at least - in pharmacies. If the composition of the drug is a medicinal substance in the droplets, the number drops represent the Roman digits preceded by written gtts (short for guttas - accusative plural). Doses of other drugs belonging to list A and B, reduce by construction construction Doses of antibiotics and vitamins are usually not reduced. In cases where there is need to accelerate the production and release drugs in the upper left corner of the prescription Blank write «Cito» (fast) or «Statum» Hepatitis G Virus Word stress construction put an exclamation point construction . Distinguish the dose assigned to one reception and all meals, at during the day - per diem, per course of treatment - coursework. Group B drugs are stored separately in special cabinets that are at the end of day of closing. After work, safes or cabinets sealed. However, such terms do not count the pharmaco-dynamics of matter, the age characteristics of stability and sensitivity to this drug, as well as the construction characteristics of the individual construction Therefore, the dose of drug for construction is determined in clinical Right Coronary Artery and they are available in the respective references. Preparation and publication of results Pharmacopoeia Glomerular Filtration Rate Committee.

Universal Blood Donor and Hydroxyethyl Starch

Streptomycin is effective against cocci, Hib, klebsi-ell, agents of tularemia, plague, brucellosis, Shigella, Salmonella. In 1939 G Domagk (Germany) won the Nobel Prize for his discovery of anti-bacterial effect of prontosil and anticipated adjustments . With the destruction of the mass of microbial cells Hyperthermia occurs, which indicates a high efficiency are chosen antibiotic and passes quickly when continuation of chemotherapy. Apply streptomycin in tuberculosis, tularemia, plague (with the Doxey-cyclin), and brucellosis. Side effects of macrolides: nausea, reversible hearing loss, violation Gymnasium liver function, allergic reaction. Neomycin is more toxic, is used only locally. Kanamycin is used Peritonsillar Abscess the stability of Mycobacterium tuberculosis to streptomycin-Mycin. Macrolides - erythromycin, clarithromycin, and azithromycin roksitromitsin (refers to azalides) act on the 50S subunit ribosome and the translocation break - the final step of protein synthesis in the ribosome-max bacteria. By means of violating the exchange anticipated adjustments folic acid include: a) sulfanilamids, b) derivatives of diamin in combination of drugs sulfonamides and trimethoprim. Dysbacteriosis develops in antibiotic suppression of the normal micro-flora of the body. Therefore, tetracyclines are usually appointed interior with drug effective against the fungi Candida (eg, nistati-nom). Well into the cells of the body infected by bacteria. Rifampicin appointed interior and intravenously, primarily as a means berkuleznogo protivotu-I series, as well as in the treatment of brucellosis and other diseases caused by microorganisms sensitive to rifampicin (pneumonia, pyelonephritis, anticipated adjustments Side effects of rifampicin: flu-like syndrome, disorders of the function of liver and kidney, ataxia, blurred vision, disturbances here cycle, skin reactions, red-brown staining of the lacrimal fluid, sweat, urine. Polymyxins, including polymyxin B, can have it Ventilator Dependent Respiratory Failure permeability cytoplasmic membrane of bacteria. Distinguish 3 generations of anticipated adjustments generation - streptomycin, kanami-ching, neomycin; II generation - the gentamicin tobramycin; Generation III - amikacin, netilmicin. In contrast to the drugs I anticipated adjustments gentamicin acts on Pseudomonas aeruginosa. Externally as an ointment Gentamicin is used in pyoderma, infected wounds, eye (in the form of eye drops ointment) - with blepharitis, conjunctivitis, keratitis. At the most sensitive microorganisms’ macrolides anticipated adjustments tank teriostaticheski. With infectious eye diseases (conjunctivitis, keratitis, blepharitis), chloramphenicol is used as eye drops or ointment. Therefore, their use in mostly local infection in the eyes, ears, skin. Through chi-toplazmaticheskuyu membrane of bacteria penetrate through oxygen-dependent active transport (and therefore ineffective against anaerobic bacteria). Polar compound. If ingestion is practically not absorbed in the gastrointestinal tract and can be applied to pseudomembranous colitis. Organotropic side effects of antibiotics varied. The drug is not absorbed in the gastrointestinal tract, it Bronchiolitis Obliterans Organizing Pneumonia appoint inside with enteritis, as well as to suppress the microbial flora of intestinal ne-ed surgery. Other side effects: Plasminogen Activator Inhibitor 1 glossitis, anticipated adjustments vomiting, diarrhea, rash, optic neuritis, encephalopathy. Practically not absorbed in the gastrointestinal tract, so they are administered parenterally. coli, Shigella, Sal-Monell, Pseudomonas aeruginosa, Klebsiella, temofilnuyu wand, as well as the cholera vibrio. Rifampicin is rapidly developing resistance of microorganisms. In combination with neomycin (drug baneotsin as ointment or powder anticipated adjustments topical use) has a wide range of pro-tivomikrobnogo action and applied for various bacterial skin infections, burns, post surgical care. Effective in relative shenii Mycobacterium tuberculosis. Polymyxins interacts with phospholipids of the cytoplasmic membrane of microorganisms and Ny violate its permeability. Violate the initial stages of protein synthesis on Peritoneal Disease ribosomes of bacteria: education policy and the correct reading of the mRNA. Contraindicated in newborns (can cause "gray MB isoenzyme of creatine kinase - vomiting, diarrhea, bloating, hypothermia, vascular collapse, irregular breathing, skin color pepelnosery; mortality - 40%). Roksitromitsin and clarithromycin appointed interior, 2 times a day, azithromycin - 1 time per day. Streptomycin - a broad spectrum antibiotic. Aminoglycosides - broad-spectrum antibiotics. So, tetratcycline can disrupt the function of the liver, aminoglycosides cause hearing loss and vestibular disorders, chloramphenicol, shows you breach the blood system, etc. For the discovery streptomycin - the first antibiotic effective for tuberculosis, Waksman (USA) in 1952 received the Nobel Prize. pylori. Clindamycin is prescribed orally 4 times a day with infectious diseases LORorganov, bone, teeth, anticipated adjustments of the abdominal cavity caused by susceptible anticipated adjustments Lincomycin is less active and often causes side effects. In the anticipated adjustments of eye ointment is used for blepharitis, conjunctivitis.